{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:23:30Z","timestamp":1791894210946,"version":"4.3.4"},"reference-count":352,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research\/Reviews in Mutation Research"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.mrrev.2014.04.001","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T06:30:28Z","timestamp":1397370628000},"page":"40-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Lymphohematopoietic cancers induced by chemicals and other agents and their implications for risk evaluation: An overview"],"prefix":"10.1016","volume":"761","author":[{"given":"David A.","family":"Eastmond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagalakshmi","family":"Keshava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babasaheb","family":"Sonawane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrrev.2014.04.001_bib0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0092-8674(91)90643-D","article-title":"Leukemia and the disruption of normal hematopoiesis","volume":"64","author":"Sawyers","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0010","series-title":"Origins of Human Cancer. A Comprehensive Review","article-title":"Origins of human leukemia: an overview","author":"Nowell","year":"1991"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0015","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"WHO","year":"2008"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0020","series-title":"Cancer Facts & Figures 2009","author":"ACS","year":"2009"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0025","series-title":"Childhood Leukemias","first-page":"19","article-title":"Diagnosis and classification","author":"Head","year":"1999"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0030","series-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"WHO","year":"2001"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.critrevonc.2004.04.008","article-title":"Modern diagnostics in acute leukemias","volume":"56","author":"Haferlach","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0040","series-title":"Childhood Leukemias","first-page":"38","article-title":"Epidemiology and etiology","author":"Bhatia","year":"1999"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0045","series-title":"Radiation Toxicology: Bone Marrow and Leukemia","first-page":"245","article-title":"The pathogenesis of leukaemia","author":"Wright","year":"1995"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.leu.2402765","article-title":"A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases","volume":"17","author":"Hasle","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0055","series-title":"Cancer Facts & Figures 2013","author":"ACS","year":"2013"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0060","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.taap.2004.11.026","article-title":"Molecular biomarkers for the study of childhood leukemia","volume":"206","author":"Smith","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0065","series-title":"Cancer Facts & Figures 2006","author":"ACS","year":"2006"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0070","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.rcl.2011.05.004","article-title":"Leukemia and lymphoma","volume":"49","author":"Guillerman","year":"2011","journal-title":"Radiol. Clin. North Am."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0075","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0959-8049(99)00296-8","article-title":"Molecular genetics, natural history and the demise of childhood leukaemia","volume":"35","author":"Greaves","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0080","series-title":"Childhood cancers \u2013 fact sheet, Bethesda, MA","author":"NCI","year":"2008"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0085","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/sj.leu.2402422","article-title":"Acute lymphoblastic leukemia incidence during socioeconomic transition: selective increase in children from 1 to 4 years","volume":"16","author":"Hrusak","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0090","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(04)17550-8","article-title":"Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study","volume":"364","author":"Steliarova-Foucher","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ni1560","article-title":"Of lineage and legacy: the development of mammalian hematopoietic stem cells","volume":"9","author":"Dzierzak","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0100","series-title":"Molecular Basis of Hematopoiesis","first-page":"47","article-title":"Hematopoietic stem cell niches","author":"Wilson","year":"2008"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0105","series-title":"The Molecular Basis of Blood Diseases","first-page":"71","article-title":"Hematopoiesis","author":"Bagby","year":"1994"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0110","series-title":"Blood: Textbook of Hematology","author":"Jandl","year":"1996"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0115","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2353\/ajpath.2006.060312","article-title":"Hematopoietic stem cells: the paradigmatic tissue-specific stem cell","volume":"169","author":"Bryder","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0120","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1749-6632.2009.04930.x","article-title":"Hematopoietic stem and progenitor cells and the inflammatory response","volume":"1174","author":"Jaiswal","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0125","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ni.1889","article-title":"Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development","volume":"11","author":"Doulatov","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0130","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ni0710-569","article-title":"Not a split decision for human hematopoiesis","volume":"11","author":"Dorshkind","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-540-68976-8_1","article-title":"Mobilization of bone marrow-derived progenitors","volume":"180","author":"Levesque","year":"2007","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0140","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12026-009-8109-6","article-title":"Hematopoietic stem and progenitor cells: their mobilization and homing to bone marrow and peripheral tissue","volume":"44","author":"Schulz","year":"2009","journal-title":"Immunol. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0145","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1182\/blood-2011-03-345165","article-title":"Differential niche and Wnt requirements during acute myeloid leukemia progression","volume":"118","author":"Lane","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0150","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.3390\/ijerph9082875","article-title":"Leukemia and benzene","volume":"9","author":"Snyder","year":"2012","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0155","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3324\/haematol.2010.028035","article-title":"Niche contributions to oncogenesis: emerging concepts and implications for the hematopoietic system","volume":"96","author":"Raaijmakers","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2010.06.003","article-title":"Effects of the bone marrow microenvironment on hematopoietic malignancy","volume":"48","author":"Askmyr","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0165","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1038\/sj.onc.1207933","article-title":"Concepts of human leukemic development","volume":"23","author":"Warner","year":"2004","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.mrrev.2014.04.001_bib0170","doi-asserted-by":"crossref","first-page":"11842","DOI":"10.1073\/pnas.2034201100","article-title":"Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?","volume":"100","author":"Passegue","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.mrrev.2014.04.001_bib0175","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/asheducation-2001.1.194","article-title":"New approaches to lymphoma diagnosis","volume":"2001","author":"Harris","year":"2001","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.genom.3.032802.115046","article-title":"Genetics of myeloid leukemias","volume":"3","author":"Kelly","year":"2002","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0185","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/sj.leu.2402500","article-title":"Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AML","volume":"16","author":"Deguchi","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0190","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood-2004-02-0754","article-title":"Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation","volume":"104","author":"Christiansen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0195","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1200\/JCO.2001.19.5.1405","article-title":"Leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis","volume":"19","author":"Christiansen","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0200","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2002-04-1010","article-title":"Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome\/acute myeloid leukemia","volume":"101","author":"Harada","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0205","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1158\/0008-5472.CAN-03-2387","article-title":"Hypermethylation of the 5\u2032 CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia","volume":"64","author":"Zheng","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0210","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1269\/jrr.46.249","article-title":"Aml1 gene rearrangements and mutations in radiation-associated acute myeloid leukemia and myelodysplastic syndromes","volume":"46","author":"Klymenko","year":"2005","journal-title":"J. Radiat. Res. (Tokyo)"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0215","first-page":"262","article-title":"Trisomy 11 in myeloid malignancies is associated with internal tandem duplication of both MLL and FLT3 genes","volume":"90","author":"Rege-Cambrin","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0220","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/sj.leu.2403641","article-title":"RAS mutation is associated with hyperdiploidy and parental characteristics in pediatric acute lymphoblastic leukemia","volume":"19","author":"Wiemels","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0225","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.leu.2405078","article-title":"Genetics of therapy-related myelodysplasia and acute myeloid leukemia","volume":"22","author":"Pedersen-Bjergaard","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0230","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","article-title":"Prognostic relevance of integrated genetic profiling in acute myeloid leukemia","volume":"366","author":"Patel","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0235","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0240","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0245","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0250","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Network","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0255","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","article-title":"The origin and evolution of mutations in acute myeloid leukemia","volume":"150","author":"Welch","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0260","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/leu.2013.58","article-title":"Clonal diversity of recurrently mutated genes in myelodysplastic syndromes","volume":"27","author":"Walter","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0265","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa1106968","article-title":"Clonal architecture of secondary acute myeloid leukemia","volume":"366","author":"Walter","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0270","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1038\/sj.leu.2404381","article-title":"Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia","volume":"20","author":"Pedersen-Bjergaard","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0275","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3324\/haematol.2012.076729","article-title":"Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia","volume":"98","author":"Shih","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0280","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1126\/science.293.5532.1103","article-title":"Genes, genetics, and epigenetics: a correspondence","volume":"293","author":"Wu","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0285","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ceb.2008.01.006","article-title":"Control of protein synthesis and mRNA degradation by microRNAs","volume":"20","author":"Liu","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0290","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1750-3639.2007.00121.x","article-title":"MicroRNAs: biogenesis and molecular functions","volume":"18","author":"Liu","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0295","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ejca.2011.02.008","article-title":"The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis","volume":"47","author":"Babashah","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0300","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1756-8722-5-7","article-title":"MicroRNAs in B cell development and malignancy","volume":"5","author":"Fernando","year":"2012","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0305","first-page":"1201","article-title":"The role of microRNAs in the pathogenesis and treatment of hematopoietic malignancies","volume":"19","author":"Schmid","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0310","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11899-009-0012-7","article-title":"MicroRNA expression in acute myeloid leukemia","volume":"4","author":"Marcucci","year":"2009","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0315","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/leu.2008.382","article-title":"The role of microRNA in human leukemia: a review","volume":"23","author":"Yendamuri","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0320","doi-asserted-by":"crossref","first-page":"19971","DOI":"10.1073\/pnas.0709313104","article-title":"MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia","volume":"104","author":"Mi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0325","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.3390\/ijerph9051939","article-title":"The aryl hydrocarbon receptor pathway: a key component of the microRNA-mediated AML signalisome","volume":"9","author":"Rager","year":"2012","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0330","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2012.08.028","article-title":"Blockade of miR-150 maturation by MLL-fusion\/MYC\/LIN-28 is required for MLL-associated leukemia","volume":"22","author":"Jiang","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0335","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nm.2054","article-title":"Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype","volume":"16","author":"Starczynowski","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/epi.3.1.5651","article-title":"Oncoproteins, heterochromatin silencing and microRNAs: a new link for leukemogenesis","volume":"3","author":"Nervi","year":"2008","journal-title":"Epigenetics"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0345","first-page":"483","article-title":"Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements","volume":"83","author":"Andersen","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0350","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0145-2126(92)90050-H","article-title":"Specific chromosomal translocations and therapy-related leukemia induced by bimolane therapy for psoriasis","volume":"16","author":"Xue","year":"1992","journal-title":"Leuk. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0355","first-page":"2176","article-title":"Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene","volume":"58","author":"Smith","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0360","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/gcc.22084","article-title":"Acute myeloid leukemia following exposure to benzene more closely resembles de novo than therapy related-disease","volume":"52","author":"Irons","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0365","series-title":"Pharmaceuticals","author":"IARC","year":"2012"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0370","series-title":"Ionizing Radiation, Part 1: X- and Gamma (g)-Radiation, and Neutrons","author":"IARC","year":"2000"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0375","series-title":"Ionizing Radiation, Part 2: Some Internally Deposited Radionuclides","author":"IARC","year":"2001"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0380","series-title":"Biological Agents","author":"IARC","year":"2012"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0385","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev.pa.36.040196.001023","article-title":"Molecular mechanisms of toxicant-induced immunosuppression: role of second messengers","volume":"36","author":"Holsapple","year":"1996","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0390","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1158\/0008-5472.CAN-08-4372","article-title":"Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis","volume":"69","author":"Vajdic","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0395","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","volume":"111","author":"Ekstrom Smedby","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0400","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2353\/ajpath.2008.071186","article-title":"CD34+ cord blood cell-transplanted Rag2\u2212\/\u2212 gamma(c)\u2212\/\u2212 mice as a model for Epstein-Barr virus infection","volume":"173","author":"Cocco","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0405","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1053\/j.gastro.2006.09.019","article-title":"Hepatitis C and risk of lymphoma: results of the European multicenter case\u2013control study EPILYMPH","volume":"131","author":"Nieters","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0410","first-page":"450","volume":"vol. 2","author":"UNSCEAR","year":"2000"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0415","first-page":"450","volume":"vol. 1","author":"UNSCEAR","year":"2000"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0420","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00004032-200307000-00011","article-title":"Cancer risks from medical radiation","volume":"85","author":"Ron","year":"2003","journal-title":"Health Phys."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0425","series-title":"Health risks from exposure to low levels of ionizing radiation, BEIR Committee on the Biological Effects of Ionizing Radiation","author":"NRC","year":"2006"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0430","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/jnci\/86.17.1315","article-title":"Relationship of leukemia risk to radiation dose following cancer of the uterine corpus","volume":"86","author":"Curtis","year":"1994","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0435","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.2307\/3578894","article-title":"Cancer incidence in atomic bomb survivors: Part IV: Comparison of cancer incidence and mortality","volume":"137","author":"Ron","year":"1994","journal-title":"Radiat Res"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0440","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1667\/RR3232","article-title":"Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates","volume":"162","author":"Preston","year":"2004","journal-title":"Radiat. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0445","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.2307\/3579806","article-title":"Ionizing radiation and cancer risk: evidence from epidemiology","volume":"150","author":"Ron","year":"1998","journal-title":"Radiat. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0450","first-page":"1295","article-title":"Radiation dose and leukemia risk in patients treated for cancer of the cervix","volume":"79","author":"Boice","year":"1987","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0455","series-title":"Health effects of exposure to low levels of ionizing radiation. BEIR Committee on the Biological Effects of Ionizing Radiation","author":"NRC","year":"1990"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0460","first-page":"57","article-title":"Toxicity of antineoplastic agents in man: chromosomal aberrations, antifertility effects, congenital malformations, and carcinogenic potential","volume":"22","author":"Seiber","year":"1975","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0465","first-page":"435","article-title":"Therapy-related leukemia and myelodysplastic syndrome","volume":"40","author":"Kantarjian","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0470","first-page":"47","article-title":"Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure","volume":"19","author":"Levine","year":"1992","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0475","first-page":"937","article-title":"The incidence of secondary leukemias","volume":"84","author":"Leone","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0480","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1200\/JCO.1992.10.1.156","article-title":"Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature","volume":"10","author":"Hunger","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0485","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2141.2001.03000.x","article-title":"Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992","volume":"114","author":"Andersen","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0490","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/cncr.22233","article-title":"Acute myeloid leukemia: epidemiology and etiology","volume":"107","author":"Deschler","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.mrrev.2014.04.001_bib0495","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/asheducation-2007.1.392","article-title":"Genetic pathways in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia","volume":"2007","author":"Pedersen-Bjergaard","year":"2007","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0500","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0165-4608(91)90246-Q","article-title":"Two different classes of therapy-related and de-novo acute myeloid leukemia?","volume":"55","author":"Pedersen-Bjergaard","year":"1991","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0505","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1182\/blood.V83.10.2780.2780","article-title":"The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation","volume":"83","author":"Pedersen-Bjergaard","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0510","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/mpo.2950230205","article-title":"Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks","volume":"23","author":"Smith","year":"1994","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0515","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2141.1987.tb01299.x","article-title":"Cytogenetic characteristics of therapy-related acute nonlymphocytic leukaemia, preleukaemia, and acute myeloproliferative syndrome: correlation with clinical data for 61 consucutive cases","volume":"66","author":"Pedersen-Bjergaard","year":"1987","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0520","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/jnci\/78.3.459","article-title":"Leukemia after therapy with alkylating agents for childhood cancer","volume":"78","author":"Tucker","year":"1987","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0525","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood.V95.11.3273","article-title":"Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation","volume":"95","author":"Pedersen-Bjergaard","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0530","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cbi.2005.03.026","article-title":"Do children have increased susceptibility for developing secondary acute myelogenous leukemia?","volume":"153\u2013154","author":"Pyatt","year":"2005","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0535","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0167-4781(98)00139-0","article-title":"Secondary leukemias induced by topoisomerase-targeted drugs","volume":"1400","author":"Felix","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0540","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cbi.2009.12.013","article-title":"Incidence and susceptibility to therapy-related myeloid neoplasms","volume":"184","author":"Leone","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0545","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/10428190109057981","article-title":"Therapy related leukemias: susceptibility, prevention and treatment","volume":"41","author":"Leone","year":"2001","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0550","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00043426-200007000-00005","article-title":"Therapy-related leukemia: is the risk life-long and can we identify patients at greatest risk","volume":"22","author":"Davies","year":"2000","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0555","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jnci\/djj017","article-title":"Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients","volume":"98","author":"Schonfeld","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0560","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cbi.2005.03.024","article-title":"Topoisomerase II inhibition by myeloperoxidase-activated hydroquinone: a potential mechanism underlying the genotoxic and carcinogenic effects of benzene","volume":"153\u2013154","author":"Eastmond","year":"2005","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0565","first-page":"91","article-title":"Reclassification of leukemia among A-bomb survivors in Nagasaki using French-American-British (FAB) classification for acute leukemia","volume":"18","author":"Matsuo","year":"1988","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0570","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0165-4608(88)90221-X","article-title":"Cytogenetic, clinical, and cytologic characteristics of radiotherapy-related leukemias","volume":"31","author":"Philip","year":"1988","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0575","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/S0140-6736(00)03501-7","article-title":"Cytogenetics of myelodysplasia and acute myeloid leukaemia in aircrew and people treated with radiotherapy","volume":"356","author":"Gundestrup","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0580","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0027-5107(98)00060-8","article-title":"Heritable and cancer risks of exposures to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents","volume":"400","author":"Vogel","year":"1998","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0585","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00043426-199305000-00015","article-title":"Acute myeloid leukemia after single-agent treatment with etoposide for Langerhans\u2019 cell histiocytosis of bone","volume":"15","author":"Haupt","year":"1993","journal-title":"Am. J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0590","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1182\/blood.V86.9.3542.bloodjournal8693542","article-title":"Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia","volume":"86","author":"Pedersen-Bjergaard","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0595","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2141.2000.01843.x","article-title":"Topoisomerase II inhibitor-related acute myeloid leukaemia","volume":"109","author":"Pui","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0600","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cncr.23988","article-title":"Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues","volume":"115","author":"Hijiya","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0605","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJM198907203210302","article-title":"Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia (see comments)","volume":"321","author":"Pui","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0610","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJM199112123252402","article-title":"Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia","volume":"325","author":"Pui","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0615","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.1073\/pnas.96.14.7624","article-title":"Benzene, NQO1, and genetic susceptibility to cancer","volume":"96","author":"Smith","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0620","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/jnci\/93.8.618","article-title":"Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study","volume":"93","author":"Neglia","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0625","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1200\/JCO.2003.04.100","article-title":"Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case\u2013control study by the Societe Francaise d\u2019Oncologie Pediatrique","volume":"21","author":"Le Deley","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0630","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/jnci\/85.7.554","article-title":"Report of the Cancer Therapy Evaluation Program monitoring plan for secondary acute myeloid leukemia following treatment with epipodophyllotoxins","volume":"85","author":"Smith","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0635","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1200\/JCO.1993.11.6.1039","article-title":"Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation","volume":"11","author":"Sandoval","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0640","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/08880019509029542","article-title":"Second malignancies associated with doxorubicin","volume":"12","author":"Blatt","year":"1995","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0645","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0027-5107(96)00024-3","article-title":"Mutagenicity of anticancer drugs that inhibit topoisomerase enzymes","volume":"355","author":"Ferguson","year":"1996","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0027-5107(96)00019-X","article-title":"The clinical use of mutagenic anticancer drugs","volume":"355","author":"Ferguson","year":"1996","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0655","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0027-5107(94)90048-5","article-title":"International Commission for Protection Against Environmental Mutagens and Carcinogens. Mutagenicity and carcinogenicity of topoisomerase-interactive agents","volume":"309","author":"Anderson","year":"1994","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0660","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrc2607","article-title":"Targeting DNA topoisomerase II in cancer chemotherapy","volume":"9","author":"Nitiss","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0665","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrc2608","article-title":"DNA topoisomerase II and its growing repertoire of biological functions","volume":"9","author":"Nitiss","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0670","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0065-230X(08)60255-9","article-title":"Molecular genetics of 11q23 chromosome translocations","volume":"66","author":"Canaani","year":"1995","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0675","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrc1164","article-title":"Origins of chromosome translocations in childhood leukaemia","volume":"3","author":"Greaves","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0680","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.dnarep.2006.05.034","article-title":"Chromosomal translocations involving the MLL gene: molecular mechanisms","volume":"5","author":"Aplan","year":"2006","journal-title":"DNA Repair (Amst.)"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0685","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.dnarep.2006.05.031","article-title":"Topoisomerase II and the etiology of chromosomal translocations","volume":"5","author":"Felix","year":"2006","journal-title":"DNA Repair (Amst.)"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0690","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.dnarep.2006.05.020","article-title":"Chromatin structural elements and chromosomal translocations in leukemia","volume":"5","author":"Zhang","year":"2006","journal-title":"DNA Repair (Amst.)"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0695","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1073\/pnas.1115704109","article-title":"DNA cleavage and opening reactions of human topoisomerase IIalpha are regulated via Mg2+-mediated dynamic bending of gate-DNA","volume":"109","author":"Lee","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0700","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1073\/pnas.1204406109","article-title":"Model for MLL translocations in therapy-related leukemia involving topoisomerase IIbeta-mediated DNA strand breaks and gene proximity","volume":"109","author":"Cowell","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0705","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1128\/MCB.17.7.4070","article-title":"DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis","volume":"17","author":"Stanulla","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0710","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1038\/sj.leu.2403966","article-title":"Cleavage of the MLL gene by activators of apoptosis is independent of topoisomerase II activity","volume":"19","author":"Betti","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0715","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cbi.2005.03.022","article-title":"Surviving apoptosis: a possible mechanism of benzene-induced leukemia","volume":"153\u2013154","author":"Vaughan","year":"2005","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0720","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/sj.leu.2404211","article-title":"MLL rearrangements emerge during spontaneous apoptosis of clinical blood samples","volume":"20","author":"Basecke","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0725","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.leukres.2006.02.005","article-title":"Lifelong persistence of AML associated MLL partial tandem duplications (MLL-PTD) in healthy adults","volume":"30","author":"Basecke","year":"2006","journal-title":"Leuk. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0730","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1182\/blood.V97.3.737","article-title":"Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals","volume":"97","author":"Eguchi-Ishimae","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0735","first-page":"668","article-title":"140 cases of acute leukemia caused by bimolane","volume":"32","author":"Zhang","year":"1993","journal-title":"Chung Hua Nei Ko Tsa Chih"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0740","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa042715","article-title":"DNA topoisomerase II in therapy-related acute promyelocytic leukemia","volume":"352","author":"Mistry","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0745","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood-2009-07-235051","article-title":"Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia","volume":"115","author":"Mays","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0750","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<1080::AID-CNCR26>3.0.CO;2-5","article-title":"Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism","volume":"86","author":"Bo","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0755","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/bmb\/ldl020","article-title":"Thiopurines, DNA damage, DNA repair and therapy-related cancer","volume":"79\u201380","author":"Karran","year":"2006","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0760","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ajh.21014","article-title":"Azathioprine-associated acute myeloid leukemia in a patient with Crohn's disease and thiopurine S-methyltransferase deficiency","volume":"83","author":"Yenson","year":"2008","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0765","first-page":"125","article-title":"Multiple-site carcinogenicity of benzene in Fischer 344 rats and B6C3F1 mice","volume":"82","author":"Huff","year":"1989","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0770","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1289\/ehp.8982109","article-title":"Benzene, an experimental multipotential carcinogen: results of the long-term bioassays performed at the Bologna Institute of Oncology","volume":"82","author":"Maltoni","year":"1989","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0775","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1006\/faat.1993.1061","article-title":"Carcinogenicity of inhaled benzene in CBA mice","volume":"20","author":"Farris","year":"1993","journal-title":"Fundam. Appl. Toxicol.: Off. J. Soc. Toxicol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0780","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0041-008X(96)80026-3","article-title":"Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression","volume":"141","author":"Valentine","year":"1996","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0785","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/15287397909529789","article-title":"Partial hepatectomy reduces both metabolism and toxicity of benzene","volume":"5","author":"Sammett","year":"1979","journal-title":"J. Toxicol. Environ. Health"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0790","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/carcin\/18.12.2421","article-title":"Tissue distribution and macromolecular binding of extremely low doses of [14C]-benzene in B6C3F1 mice","volume":"18","author":"Creek","year":"1997","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0795","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/carcin\/16.8.1803","article-title":"DNA adduct formation in the bone marrow of B6C3F1 mice treated with benzene","volume":"16","author":"Pathak","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0800","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/taap.1999.8707","article-title":"Species and strain comparisons in the macromolecular binding of extremely low doses of [14C]benzene in rodents, using accelerator mass spectrometry","volume":"159","author":"Mani","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0805","series-title":"A review of human carcinogens \u2013 Part F: Chemical agents and related occupations, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans","author":"IARC","year":"2012"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0810","series-title":"Toxicological Profile for Benzene","author":"ATSDR","year":"2007"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0815","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1383-5742(03)00053-X","article-title":"Genotoxicity of benzene and its metabolites","volume":"566","author":"Whysner","year":"2004","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0820","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/em.20368","article-title":"Evaluating genotoxicity data to identify a mode of action and its application in estimating cancer risk at low doses: a case study involving carbon tetrachloride","volume":"49","author":"Eastmond","year":"2008","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0825","first-page":"1","article-title":"Characterization and mechanisms of chromosomal alterations induced by benzene in mice and humans","author":"Eastmond","year":"2001","journal-title":"Res. Rep. Health Effects Inst."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0830","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cbi.2009.12.019","article-title":"Hprt mutant frequency and p53 gene status in mice chronically exposed by inhalation to benzene","volume":"184","author":"Albertini","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0835","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0027-5107(92)90082-D","article-title":"The mutagenic effects of low level sub-acute inhalation exposure to benzene in CD-1 mice","volume":"268","author":"Ward","year":"1992","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0840","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0027-5107(94)00181-4","article-title":"Inhalation of benzene leads to an increase in the mutant frequencies of a lacI transgene in lung and spleen tissues of mice","volume":"327","author":"Mullin","year":"1995","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0845","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/(SICI)1098-2280(1996)28:4<342::AID-EM7>3.0.CO;2-D","article-title":"Mutagenic response to benzene and tris(2,3-dibromopropyl)-phosphate in the lambda lacI transgenic mouse mutation assay: a standardized approach to in vivo mutation analysis","volume":"28","author":"Provost","year":"1996","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0850","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/20024091064165","article-title":"The nature of chromosomal aberrations detected in humans exposed to benzene","volume":"32","author":"Zhang","year":"2002","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0855","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1038\/leu.2012.143","article-title":"Leukemia-related chromosomal loss detected in hematopoietic progenitor cells of benzene-exposed workers","volume":"26","author":"Zhang","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0860","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/carcin\/19.11.1955","article-title":"Increased aneusomy and long arm deletion of chromosomes 5 and 7 in the lymphocytes of Chinese workers exposed to benzene","volume":"19","author":"Zhang","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0865","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1073\/pnas.92.9.4069","article-title":"Benzene induces gene-duplicating but not gene-inactivating mutations at the glycophorin A locus in exposed humans","volume":"92","author":"Rothman","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0870","series-title":"Benzene Carcinogenicity","first-page":"23","article-title":"Experimental benzene toxicity","author":"Snyder","year":"1988"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0875","first-page":"69","article-title":"Benzene toxicity: a critical evaluation: hematotoxicity in humans","volume":"2","author":"Goldstein","year":"1977","journal-title":"J. Toxicol. Environ. Health Suppl."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0880","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/carcin\/bgr297","article-title":"Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment","volume":"33","author":"McHale","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0885","series-title":"Benzene Carcinogenicity","first-page":"59","article-title":"Benzene hematotoxicity","author":"Aksoy","year":"1988"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0890","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.leukres.2005.08.019","article-title":"Chronic exposure to benzene results in a unique form of dysplasia","volume":"29","author":"Irons","year":"2005","journal-title":"Leuk. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0895","series-title":"Benzene Carcinogenicity","first-page":"113","article-title":"Benzene carcinogenicity","author":"Aksoy","year":"1988"},{"issue":"Suppl. 6","key":"10.1016\/j.mrrev.2014.04.001_bib0900","first-page":"1431","article-title":"Leukemia risk associated with benzene exposure in the Pliofilm cohort","volume":"104","author":"Paxton","year":"1996","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0905","first-page":"124","article-title":"Leukaemia in benzene workers: a retrospective cohort study","volume":"44","author":"Yin","year":"1987","journal-title":"Br. J. Ind. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0910","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/ajim.10138","article-title":"Benzene exposure and hematopoietic mortality: a long-term epidemiologic risk assessment","volume":"42","author":"Rinsky","year":"2002","journal-title":"Am. J. Ind. Med."},{"issue":"Suppl. 6","key":"10.1016\/j.mrrev.2014.04.001_bib0915","first-page":"1239","article-title":"The process of leukemogenesis","volume":"104","author":"Irons","year":"1996","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0925","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cbi.2009.10.017","article-title":"A hospital-based case\u2013control study of acute myeloid leukemia in Shanghai: analysis of environmental and occupational risk factors by subtypes of the WHO classification","volume":"184","author":"Wong","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0930","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1093\/carcin\/16.10.2301","article-title":"Topoisomerase inhibition by phenolic metabolites: a potential mechanism for benzene's clastogenic effects","volume":"16","author":"Chen","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0935","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cbi.2009.12.023","article-title":"Topoisomerase II inhibition by the bioactivated benzene metabolite hydroquinone involves multiple mechanisms","volume":"184","author":"Mondrala","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0940","first-page":"162","article-title":"Molecular characterization of acute myeloblastic leukemia according to the new WHO classification: a different distribution in Central-West Spain","volume":"86","author":"Chillon","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0945","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gcc.2870030102","article-title":"Geographic heterogeneity of neoplasia-associated chromosome aberrations","volume":"3","author":"Johansson","year":"1991","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0950","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/(SICI)1097-0215(19970328)71:1<9::AID-IJC3>3.0.CO;2-Y","article-title":"Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans\u2019 cell histiocytosis in Italian and Austrian-German populations","volume":"71","author":"Haupt","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0955","series-title":"Ethylene Oxide","author":"IARC","year":"2008"},{"issue":"1","key":"10.1016\/j.mrrev.2014.04.001_bib0960","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1093\/toxsci\/kfq371","article-title":"Endogenous versus exogenous DNA adducts: their role in carcinogenesis, epidemiology, and risk assessment","volume":"120","author":"Swenberg","year":"2011","journal-title":"Toxicol. Sci.: Off. J. Soc. Toxicol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0965","first-page":"4328","article-title":"Molecular dosimetry of ethylene oxide: formation and persistence of 7-(2-hydroxyethyl)guanine in DNA following repeated exposures of rats and mice","volume":"52","author":"Walker","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0970","series-title":"Ethylene Oxide","author":"IARC","year":"1994"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0975","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/carcin\/bgn075","article-title":"Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22,358 subjects in 11 countries","volume":"29","author":"Bonassi","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrrev.2014.04.001_bib0980","first-page":"308","article-title":"Toxicity of ethylene oxide on the lens and on leukocytes: an epidemiological study in hospital sterilisation installations","volume":"47","author":"Deschamps","year":"1990","journal-title":"Br. J. Ind. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0985","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00043764-199503000-00008","article-title":"Molecular, cytogenetic, and hematologic effects of ethylene oxide on female hospital workers","volume":"37","author":"Schulte","year":"1995","journal-title":"J. Occup. Environ. Med.\/Am. Coll. Occup. Environ. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0990","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ajim.4700240206","article-title":"Utility of the complete blood count in routine medical surveillance for ethylene oxide exposure","volume":"24","author":"LaMontagne","year":"1993","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib0995","series-title":"Haematologic Studies on Persons Occupationally Exposed to Ethylene Oxide","first-page":"327","author":"Ehrenberg","year":"1967"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1000","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S1470-2045(09)70358-4","article-title":"A review of human carcinogens\u2014Part F: chemical agents and related occupations","volume":"10","author":"Baan","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1005","series-title":"1,3-Butadiene","author":"IARC","year":"1999"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1010","series-title":"1,3-Butadiene","author":"IARC","year":"2008"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1015","first-page":"195","article-title":"Mutagenicity of 1,3-butadiene and its epoxide metabolites in human TK6 cells and in splenic T cells isolated from exposed B6C3F1 mice","volume":"127","author":"Cochrane","year":"1993","journal-title":"IARC Sci. Publ."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1020","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/carcin\/15.4.719","article-title":"Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice","volume":"15","author":"Cochrane","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1025","series-title":"Formaldehyde","author":"IARC","year":"2006"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1030","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/toxsci\/kfq061","article-title":"Distribution of DNA adducts caused by inhaled formaldehyde is consistent with induction of nasal carcinoma but not leukemia","volume":"116","author":"Lu","year":"2010","journal-title":"Toxicol. Sci.: Off. J. Soc. Toxicol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1035","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/(SICI)1098-2280(1998)32:3<260::AID-EM9>3.0.CO;2-M","article-title":"Significance of formaldehyde-induced DNA-protein crosslinks for mutagenesis","volume":"32","author":"Merk","year":"1998","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1040","series-title":"Report of Carcinogens Background Document Formaldehyde","first-page":"512","author":"NTP","year":"2010"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1045","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1021\/tx1004166","article-title":"Determination of N2-hydroxymethyl-dG adducts in the nasal epithelium and bone marrow of nonhuman primates following 13CD2-formaldehyde inhalation exposure","volume":"24","author":"Moeller","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1021\/tx1003886","article-title":"Molecular dosimetry of N2-hydroxymethyl-dG DNA adducts in rats exposed to formaldehyde","volume":"24","author":"Lu","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1055","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.toxlet.2013.10.028","article-title":"Formaldehyde induces micronuclei in mouse erythropoietic cells and suppresses the expansion of human erythroid progenitor cells","volume":"224","author":"Ji","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1060","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/em.21821","article-title":"Inhaled formaldehyde induces DNA-protein crosslinks and oxidative stress in bone marrow and other distant organs of exposed mice","volume":"54","author":"Ye","year":"2013","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1065","doi-asserted-by":"crossref","first-page":"e74974","DOI":"10.1371\/journal.pone.0074974","article-title":"Bone marrow injury induced via oxidative stress in mice by inhalation exposure to formaldehyde","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.toxlet.2013.04.024","article-title":"Attenuation of subchronic formaldehyde inhalation toxicity with oral administration of glutamate, glycine and methionine","volume":"220","author":"Katsnelson","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1075","first-page":"3085","article-title":"Evaluation of genotoxic effects of formaldehyde in adult albino rats and its implication in case of human exposure","volume":"9","author":"Gomaa","year":"2012","journal-title":"Life Sci. J."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1080","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.toxlet.2013.09.008","article-title":"Formaldehyde exposure impairs the function and differentiation of NK cells","volume":"223","author":"Kim","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1085","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.mrrev.2011.07.003","article-title":"Reproductive and developmental toxicity of formaldehyde: a systematic review","volume":"728","author":"Duong","year":"2011","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1090","series-title":"Final report on carcinogens background document for formaldehyde, Report on carcinogens background document for [substance name]","first-page":"i","author":"NTP","year":"2010"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1191\/0748233705th235oa","article-title":"Effect of formaldehyde inhalation on Hsp70 in seminiferous tubules of rat testes: an immunohistochemical study","volume":"21","author":"Ozen","year":"2005","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jchemneu.2005.01.001","article-title":"Vitamin E against oxidative damage caused by formaldehyde in frontal cortex and hippocampus: biochemical and histological studies","volume":"29","author":"Gurel","year":"2005","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1105","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/15287390902841615","article-title":"Exposure to formaldehyde induces heritable DNA mutations in mice","volume":"72","author":"Liu","year":"2009","journal-title":"J. Toxicol. Environ. Health A"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mrgentox.2006.10.013","article-title":"Assessment of local genotoxic effects of formaldehyde in humans measured by the micronucleus test with exfoliated buccal mucosa cells","volume":"627","author":"Speit","year":"2007","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.mrrev.2008.07.002","article-title":"Formaldehyde exposure and leukemia: a new meta-analysis and potential mechanisms","volume":"681","author":"Zhang","year":"2009","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1120","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.envint.2009.06.002","article-title":"Formaldehyde in China: production, consumption, exposure levels, and health effects","volume":"35","author":"Tang","year":"2009","journal-title":"Environ. Int."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1125","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ajim.22088","article-title":"Occupational exposure to formaldehyde and alterations in lymphocyte subsets","volume":"56","author":"Hosgood","year":"2013","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1158\/1055-9965.EPI-09-0762","article-title":"Occupational exposure to formaldehyde, hematotoxicity, and leukemia-specific chromosome changes in cultured myeloid progenitor cells","volume":"19","author":"Zhang","year":"2010","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yrtph.2004.04.006","article-title":"A review and meta-analysis of formaldehyde exposure and leukemia","volume":"40","author":"Collins","year":"2004","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1140","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/JOM.0b013e3181ef7e31","article-title":"Formaldehyde and leukemia: an updated meta-analysis and evaluation of bias","volume":"52","author":"Schwilk","year":"2010","journal-title":"J. Occup. Environ. Med.\/Am. Coll. Occup. Environ. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/10408440903341696","article-title":"Epidemiological studies of formaldehyde exposure and risk of leukemia and nasopharyngeal cancer: a meta-analysis","volume":"40","author":"Bachand","year":"2010","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1150","first-page":"195","article-title":"Report on carcinogens: carcinogen profiles\/U.S Dept. of Health and Human Services, Public Health Service","volume":"12","author":"Formaldehyde","year":"2011","journal-title":"Natl. Toxicol. Program"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1155","series-title":"Review of the Environmental Protection Agency's Draft IRIS Assessment of Formaldehyde","author":"NRC","year":"2011"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1160","series-title":"Chemical and Radiation Leukemogenesis in Humans and Rodents and the Value of Rodent Models for Assessing Risks of Lymphohematopoietic Cancers","author":"Eastmond","year":"1997"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1165","series-title":"Hematopoiesis: Long-term Effects of Chemotherapy and Radiation","first-page":"63","article-title":"Myelosuppressive effects of antineoplastic chemotherapy","author":"Gale","year":"1988"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1170","series-title":"Radiation Toxicology: Bone Marrow and Leukemia","first-page":"91","article-title":"Response of bone marrow to low LET irradiation","author":"Hendry","year":"1995"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1175","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00007435-198410001-00007","article-title":"Aplastic anemia due to chemicals and drugs: a study of 108 patients","volume":"11","author":"Aksoy","year":"1984","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1180","series-title":"Blood: Textbook of Hematology","author":"Jandl","year":"1987"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1185","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1182\/blood.V90.3.1009","article-title":"Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia","volume":"90","author":"Ohara","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1190","first-page":"ECR31","article-title":"Detection of myelodysplastic syndrome\/acute myeloid leukemia evolving from aplastic anemia in children, treated with recombinant human G-CSF","volume":"88","author":"Imashuku","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1195","series-title":"The Identification and Control of Environmental and Occupational Diseases: Hazards and Risks of Chemicals in the Oil Refining Industry","first-page":"287","article-title":"Benzene risk and it prevention in China","author":"Yin","year":"1994"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1200","series-title":"Toxicological and Epidemiological Studies on Benzene in China","article-title":"Study on the program for diagnosis of benzene leukemia","author":"Yin","year":"1994"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1205","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ajim.10121","article-title":"Hematological changes among Chinese workers with a broad range of benzene exposures","volume":"42","author":"Qu","year":"2002","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1210","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1102443","article-title":"Hematotoxicity in workers exposed to low levels of benzene","volume":"306","author":"Lan","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrc1800","article-title":"Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy","volume":"6","author":"Cheok","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1220","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.pharmtox.45.120403.100018","article-title":"Pharmacogenomics of acute leukemia","volume":"46","author":"Cheok","year":"2006","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1225","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10689-005-2574-4","article-title":"Challenges identifying genetic determinants of pediatric cancers\u2014the childhood leukemia experience","volume":"5","author":"Sinnett","year":"2006","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1230","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2141.2007.06613.x","article-title":"Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia","volume":"137","author":"Seedhouse","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1235","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000338480","article-title":"Human leukocyte antigen (HLA)-DRB1*14 is associated with a high incidence of acute lymphocytic leukemia","volume":"35","author":"Zhou","year":"2012","journal-title":"Onkologie"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1240","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bcmd.2003.10.005","article-title":"Familial (inherited) leukemia, lymphoma, and myeloma: an overview","volume":"32","author":"Segel","year":"2004","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1245","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1438::AID-CNCR22>3.0.CO;2-#","article-title":"Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1","volume":"79","author":"Maris","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1250","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.biochi.2003.10.007","article-title":"Human mismatch repair, drug-induced DNA damage, and secondary cancer","volume":"85","author":"Karran","year":"2003","journal-title":"Biochimie"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1255","first-page":"3012","article-title":"An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents","volume":"9","author":"Worrillow","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1260","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/carcin\/bgl061","article-title":"Polymorphisms in genes involved in DNA double strand repair pathway and susceptibility to benzene-induced hematotoxicity","volume":"27","author":"Shen","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1265","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/15287390701738558","article-title":"Association of the NQO1, MPO, and XRCC1 polymorphisms and chromosome damage among workers at a petroleum refinery","volume":"71","author":"Kim","year":"2008","journal-title":"J. Toxicol. Environ. Health A"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1270","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.taap.2008.09.008","article-title":"Genetic polymorphisms in hMTH1, hOGG1 and hMYH and risk of chronic benzene poisoning in a Chinese occupational population","volume":"233","author":"Wu","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1275","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/oem.2008.044024","article-title":"Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity","volume":"66","author":"Hosgood","year":"2009","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1280","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.taap.2009.07.003","article-title":"Association of genetic polymorphisms in GADD45A, MDM2, and p14 ARF with the risk of chronic benzene poisoning in a Chinese occupational population","volume":"240","author":"Sun","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1285","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<1080::AID-CNCR26>3.0.CO;2-5","article-title":"Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism","volume":"86","author":"Thomsen","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1290","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.leu.2404016","article-title":"The Eighth International Childhood Acute Lymphoblastic Leukemia Workshop (\u2019Ponte di legno meeting\u2019) report: Vienna, Austria, April 27\u201328 2005","volume":"20","author":"Gadner","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1295","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3324\/haematol.11034","article-title":"Therapy-related leukemia and myelodysplasia: susceptibility and incidence","volume":"92","author":"Leone","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1300","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/10428190701769657","article-title":"Influence of DNA damage and repair upon the risk of treatment related leukemia","volume":"49","author":"Guillem","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1305","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cbi.2010.10.008","article-title":"Benzene toxicity: the role of the susceptibility factor NQO1 in bone marrow endothelial cell signaling and function","volume":"192","author":"Ross","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1310","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1182\/blood.V94.2.803","article-title":"Prevalence of the inactivating 609C\u2192T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia","volume":"94","author":"Larson","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1315","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood.V97.5.1422","article-title":"Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults","volume":"97","author":"Smith","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1320","first-page":"4095","article-title":"A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators","volume":"59","author":"Wiemels","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1325","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1182\/blood-2001-12-0264","article-title":"Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children","volume":"100","author":"Smith","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1330","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00008571-200211000-00004","article-title":"Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies","volume":"12","author":"Blanco","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1335","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/pbc.20098","article-title":"NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia","volume":"43","author":"Sirma","year":"2004","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1340","first-page":"1511","article-title":"The association of a distinctive allele of NAD(P)H:quinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan","volume":"90","author":"Eguchi-Ishimae","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1345","first-page":"956","article-title":"The frequencies of NAD(P)H quinone oxidoreductase (NQO1) variant allele in Israeli ethnic groups and the relationship of NQO1*2 to adult acute myeloid leukemia in Israeli patients","volume":"91","author":"Malik","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1350","first-page":"2839","article-title":"Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C\u2192T mutation and rapid fractional excretion of chlorzoxazone","volume":"57","author":"Rothman","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1355","series-title":"Guidelines for Carcinogen Risk Assessment","author":"EPA","year":"2005"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1360","volume":"Suppl. 6","author":"IARC","year":"1987"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1365","first-page":"4117","article-title":"Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Stud y Group on Cytogenetic Biomarkers and Health (ESCH)","volume":"58","author":"Hagmar","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1370","first-page":"1481","article-title":"Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area","volume":"59","author":"Liou","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1375","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1289\/ehp.0110941","article-title":"Risk of cancer in an occupationally exposed cohort with increased level of chromosomal aberrations","volume":"109","author":"Smerhovsky","year":"2001","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1380","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1158\/0008-5472.CAN-03-3360","article-title":"Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts","volume":"64","author":"Hagmar","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1385","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/aje\/kwj367","article-title":"Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe","volume":"165","author":"Boffetta","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1390","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/carcin\/bgl177","article-title":"An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans","volume":"28","author":"Bonassi","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1395","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cbi.2009.12.021","article-title":"Benzene as a cause of lymphoproliferative disorders","volume":"184","author":"Goldstein","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1400","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1289\/ehp.898297","article-title":"Hematotoxicity and carcinogenicity of inhaled benzene","volume":"82","author":"Cronkite","year":"1989","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1405","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0092-8674(00)81269-6","article-title":"An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes","volume":"85","author":"Corral","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1410","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1093\/emboj\/18.13.3564","article-title":"The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis","volume":"18","author":"Dobson","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1415","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1093\/emboj\/19.17.4655","article-title":"Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia","volume":"19","author":"Lavau","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1420","doi-asserted-by":"crossref","first-page":"10984","DOI":"10.1073\/pnas.190167297","article-title":"Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice","volume":"97","author":"Lavau","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1425","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1535-6108(03)00106-5","article-title":"Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer","volume":"3","author":"Forster","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1430","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1535-6108(03)00019-9","article-title":"MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice","volume":"3","author":"So","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1435","series-title":"Preamble","author":"IARC","year":"2008"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1440","unstructured":"IARC, General Remarks, International Agency for Research on Cancer, Lyon, 2008."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1445","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/intimm\/dxp125","article-title":"A revised scheme for developmental pathways of hematopoietic cells: the myeloid-based model","volume":"22","author":"Kawamoto","year":"2010","journal-title":"Int. Immunol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1450","first-page":"357","article-title":"Risk of myelogenous leukaemia and multiple myeloma in workers exposed to benzene","volume":"53","author":"Savitz","year":"1996","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1455","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/(SICI)1097-0274(199703)31:3<287::AID-AJIM4>3.0.CO;2-V","article-title":"Review of epidemiologic evidence on benzene and lymphatic and hematopoietic cancers","volume":"31","author":"Savitz","year":"1997","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1460","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1158\/1055-9965.EPI-06-1057","article-title":"Benzene exposure and risk of non-Hodgkin lymphoma","volume":"16","author":"Smith","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1465","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/oem.2007.036913","article-title":"Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases could mask an important association","volume":"65","author":"Steinmaus","year":"2008","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1470","series-title":"A Review of Human Carcinogens: Chemical Agents and Related Occupations, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans","author":"IARC","year":"2012"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1475","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/oem.2011.064865","article-title":"Association between cleaning-related chemicals and work-related asthma and asthma symptoms among healthcare professionals","volume":"69","author":"Arif","year":"2012","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1480","series-title":"Review of the Environmental Protection Agency's Draft IRIS Assessment of Formaldehyde","author":"NRC","year":"2011"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1485","series-title":"Alkeran (melphalan) tablets","first-page":"8","author":"GlaxoSmithKline","year":"2007"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1490","first-page":"1318","article-title":"Plasma pharmacokinetics of high-dose oral melphalan in patients treated with trialkylator chemotherapy and autologous bone marrow reinfusion","volume":"49","author":"Choi","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1495","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1081\/DMR-200033445","article-title":"Xenobiotic metabolism and the mechanism(s) of benzene toxicity","volume":"36","author":"Snyder","year":"2004","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1500","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/1568009043333014","article-title":"The role of cytochrome P450 in cytotoxic bioactivation: future therapeutic directions","volume":"4","author":"Rooney","year":"2004","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1505","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.toxlet.2008.09.008","article-title":"NQO1, MPO, CYP2E1, GSTT1 and GSTM1 polymorphisms and biological effects of benzene exposure\u2014a literature review","volume":"182","author":"Dougherty","year":"2008","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199001043220101","article-title":"Leukemia following chemotherapy for ovarian cancer","volume":"322","author":"Kaldor","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1515","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.2307\/3578893","article-title":"Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950\u20131987","volume":"137","author":"Preston","year":"1994","journal-title":"Radiat. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1520","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/15287390600975061","article-title":"Is age an independent risk factor for chemically induced acute myelogenous leukemia in children?","volume":"10","author":"Pyatt","year":"2007","journal-title":"J. Toxicol. Environ. Health B: Crit. Rev."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1525","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood.V44.6.837.837","article-title":"Leukemia in shoe-workers exposed chronically to benzene","volume":"44","author":"Aksoy","year":"1974","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1530","series-title":"Benzene Carcinogenicity","first-page":"113","article-title":"Benzene hematoxicity","author":"Aksoy","year":"1988"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1535","series-title":"Blood dyscrasia in unoffical vendors of petrol and heavy oil and motor mechanics in Nigeria","first-page":"55","author":"Niazi","year":"1989"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1540","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mrrev.2005.04.003","article-title":"Children's exposure to environmental pollutants and biomarkers of genetic damage. II. Results of a comprehensive literature search and meta-analysis","volume":"612","author":"Neri","year":"2006","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1545","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0027-5107(01)00211-1","article-title":"Susceptibility differences in chemical carcinogenesis linearize the dose\u2013response relationship: threshold doses can be defined only for individuals","volume":"482","author":"Lutz","year":"2001","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1550","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/carcin\/11.8.1243","article-title":"Dose\u2013response relationship and low dose extrapolation in chemical carcinogenesis","volume":"11","author":"Lutz","year":"1990","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1555","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cbi.2009.11.025","article-title":"Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia","volume":"184","author":"Qian","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1560","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ccr.2011.09.011","article-title":"Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia\/acute myeloid leukemia and identifies patients at risk","volume":"20","author":"Li","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1565","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cbi.2005.03.023","article-title":"Therapy-related myeloid leukaemia: a model for leukemogenesis in humans","volume":"153\u2013154","author":"Larson","year":"2005","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1570","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1182\/blood-2013-07-517953","article-title":"Haploinsufficiency of del(5q) genes, Egr1 and Apc, cooperate with Tp53 loss to induce acute myeloid leukemia in mice","volume":"123","author":"Stoddart","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1575","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/leu.2009.53","article-title":"Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer","volume":"23","author":"Ebert","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1580","first-page":"365","article-title":"Deletion 5q MDS: molecular and therapeutic implications. Best practice & research","volume":"26","author":"Komrokji","year":"2013","journal-title":"Clin. Haematol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1585","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1053\/j.seminoncol.2011.04.010","article-title":"Molecular dissection of the 5q deletion in myelodysplastic syndrome","volume":"38","author":"Ebert","year":"2011","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1590","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cancergen.2011.02.001","article-title":"A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes","volume":"204","author":"MacKinnon","year":"2011","journal-title":"Cancer Genet."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1595","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cbi.2005.03.017","article-title":"Use of \u2018Omic\u2019 technologies to study humans exposed to benzene","volume":"153\u2013154","author":"Smith","year":"2005","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1600","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1470-2045(08)70286-9","article-title":"A review of human carcinogens\u2014Part A: pharmaceuticals","volume":"10","author":"Grosse","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1605","volume":"Suppl. 7","author":"IARC","year":"1987"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1610","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0027-5107(96)00021-8","article-title":"Mutagenic damage to mammalian cells by therapeutic alkylating agents","volume":"355","author":"Sanderson","year":"1996","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1615","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0165-1110(86)90020-5","article-title":"Toxicological review of busulfan (Myleran)","volume":"168","author":"Bishop","year":"1986","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1620","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0165-7992(92)90125-2","article-title":"Cytogenetic and molecular characterization of the mutagenicity of chlorambucil in V79 cells","volume":"283","author":"Speit","year":"1992","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1625","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/nature03958","article-title":"Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines","volume":"437","author":"Shi","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1630","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/mutage\/13.6.607","article-title":"Mutation studies in lacI transgenic mice after exposure to radiation or cyclophosphamide","volume":"13","author":"Hoyes","year":"1998","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1635","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/sj.bjc.6690043","article-title":"DNA alkylation and interstrand cross-linking by treosulfan","volume":"79","author":"Hartley","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1640","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/ctrv.2000.0170","article-title":"Chemistry, pharmacology and pharmacokinetics of N,N\u2032,N\u2033-triethylenethiophosphoramide (ThioTEPA)","volume":"26","author":"Maanen","year":"2000","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1645","series-title":"Toxicological Profile for 1,3-butadiene","author":"ATSDR","year":"2012"},{"issue":"Suppl. 1","key":"10.1016\/j.mrrev.2014.04.001_bib1650","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/10408444.2010.507182","article-title":"1,3-Butadiene: II. Genotoxicity profile","volume":"40","author":"Albertini","year":"2010","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1655","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1470-2045(09)70213-X","article-title":"A review of human carcinogens\u2014Part D: radiation","volume":"10","author":"El Ghissassi","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1660","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/sj.leu.2401089","article-title":"Etoposide-related acute promyelocytic leukemia","volume":"12","author":"Kudo","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1665","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/gcc.10046","article-title":"11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop","volume":"33","author":"Bloomfield","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1670","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nri803","article-title":"Effects of cigarette smoke on the immune system","volume":"2","author":"Sopori","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1675","series-title":"Tobacco Smoke and Involuntary Smoking","author":"IARC","year":"2004"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1680","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1470-2045(09)70326-2","article-title":"A review of human carcinogens\u2014Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish","volume":"10","author":"Secretan","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1685","series-title":"Cyclosporin","author":"IARC","year":"1990"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1690","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1695","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/01480549209032293","article-title":"Immunosuppression and cancer: the ciclosporin case","volume":"15","author":"Ryffel","year":"1992","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1700","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1349-7006.1989.tb02330.x","article-title":"Induction of uterine hemangioendothelioma and lymphoma in (C57BL\/6N\u00d7C3H\/2N)F1 mice by oral administration of azathioprine","volume":"80","author":"Ito","year":"1989","journal-title":"Jpn. J. Cancer Res.: Gann"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1705","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S1470-2045(12)70485-0","article-title":"International Agency for Research on Cancer Monograph Working, Carcinogenicity of trichloroethylene, tetrachloroethylene, some other chlorinated solvents, and their metabolites","volume":"13","author":"Guha","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1710","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2796.2008.02031.x","article-title":"Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence","volume":"264","author":"Hjalgrim","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1715","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mrrev.2014.04.001_bib1720","series-title":"Human T-Cell Lymphotrophic Viruses","author":"IARC","year":"1996"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1725","series-title":"Chlorozotocin","author":"IARC","year":"1990"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1730","series-title":"Teniposide","author":"IARC","year":"2000"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1735","series-title":"The Report of Carcinogens","author":"NTP","year":"2005"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1740","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.23607","article-title":"Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine","volume":"123","author":"Stresemann","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1745","series-title":"IARC Monographs on Occupational Exposures in Petroleum Refining, Crude Oil and Major Petroleum Fuels","author":"IARC","year":"1989"},{"key":"10.1016\/j.mrrev.2014.04.001_bib1750","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1470-2045(12)70125-0","article-title":"Carcinogenicity of malaria and of some polyomaviruses","volume":"13","author":"Bouvard","year":"2012","journal-title":"Lancet Oncol."},{"issue":"7487","key":"10.1016\/j.mrrev.2014.04.001_bib1755","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nature12883","article-title":"Leukaemogenesis induced by an activating \u03b2-catenin mutation in osteoblasts","volume":"506","author":"Kode","year":"2014","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.mrrev.2014.04.001_bib1760","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3109\/10408444.2011.560140","article-title":"Is exposure to formaldehyde in air causally associated with leukemia?\u2013A hypothesis-based weight-of-evidence analysis","volume":"41","author":"Rhomberg","year":"2011","journal-title":"Crit. Rev. Toxicol."},{"issue":"1","key":"10.1016\/j.mrrev.2014.04.001_bib1765","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.yrtph.2008.03.003","article-title":"Is inhalation exposure to formaldehyde a biologically plausible cause of lymphohematopoietic malignancies?","volume":"51","author":"Pyatt","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."}],"container-title":["Mutation Research\/Reviews in Mutation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574214000209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574214000209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:16:16Z","timestamp":1761300976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383574214000209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":352,"alternative-id":["S1383574214000209"],"URL":"https:\/\/doi.org\/10.1016\/j.mrrev.2014.04.001","relation":{},"ISSN":["1383-5742"],"issn-type":[{"value":"1383-5742","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphohematopoietic cancers induced by chemicals and other agents and their implications for risk evaluation: An overview","name":"articletitle","label":"Article Title"},{"value":"Mutation Research\/Reviews in Mutation Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrrev.2014.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}